162 related articles for article (PubMed ID: 35618418)
1. Frequent somatic gene conversion as a mechanism for loss of heterozygosity in tumor suppressor genes.
Takahashi KK; Innan H
Genome Res; 2022 Jun; 32(6):1017-1025. PubMed ID: 35618418
[TBL] [Abstract][Full Text] [Related]
2. Ever since Knudson.
Devilee P; Cleton-Jansen AM; Cornelisse CJ
Trends Genet; 2001 Oct; 17(10):569-73. PubMed ID: 11585662
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene.
Cheng CW; Wu PE; Yu JC; Huang CS; Yue CT; Wu CW; Shen CY
Oncogene; 2001 Jun; 20(29):3814-23. PubMed ID: 11439345
[TBL] [Abstract][Full Text] [Related]
5. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.
Gorringe KL; Ramakrishna M; Williams LH; Sridhar A; Boyle SE; Bearfoot JL; Li J; Anglesio MS; Campbell IG
Genes Chromosomes Cancer; 2009 Oct; 48(10):931-42. PubMed ID: 19603523
[TBL] [Abstract][Full Text] [Related]
6. Patterns of somatic uniparental disomy identify novel tumor suppressor genes in colorectal cancer.
Torabi K; Miró R; Fernández-Jiménez N; Quintanilla I; Ramos L; Prat E; del Rey J; Pujol N; Killian JK; Meltzer PS; Fernández PL; Ried T; Lozano JJ; Camps J; Ponsa I
Carcinogenesis; 2015 Oct; 36(10):1103-10. PubMed ID: 26243311
[TBL] [Abstract][Full Text] [Related]
7. Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview.
Wang LH; Wu CF; Rajasekaran N; Shin YK
Cell Physiol Biochem; 2018; 51(6):2647-2693. PubMed ID: 30562755
[TBL] [Abstract][Full Text] [Related]
8. ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.
Cleton-Jansen AM; van Eijk R; Lombaerts M; Schmidt MK; Van't Veer LJ; Philippo K; Zimmerman RM; Peterse JL; Smit VT; van Wezel T; Cornelisse CJ
BMC Cancer; 2008 Apr; 8():105. PubMed ID: 18416817
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity: what is it good for?
Ryland GL; Doyle MA; Goode D; Boyle SE; Choong DY; Rowley SM; Li J; ; Bowtell DD; Tothill RW; Campbell IG; Gorringe KL
BMC Med Genomics; 2015 Aug; 8():45. PubMed ID: 26231170
[TBL] [Abstract][Full Text] [Related]
11. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
Pollock PM; Welch J; Hayward NK
Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
[TBL] [Abstract][Full Text] [Related]
12. Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene.
Ma H; Weng D; Chen Y; Huang W; Pan K; Wang H; Sun J; Wang Q; Zhou Z; Wang H; Xia J
Mol Cancer; 2010 Jul; 9():190. PubMed ID: 20626849
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity at loci of candidate tumor suppressor genes in microdissected primary non-small cell lung cancer.
Ho WL; Chang JW; Tseng RC; Chen JT; Chen CY; Jou YS; Wang YC
Cancer Detect Prev; 2002; 26(5):343-9. PubMed ID: 12518864
[TBL] [Abstract][Full Text] [Related]
14. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation study of the H37/RBM5 tumor suppressor gene from the 3p21.3 human lung cancer tumor suppressor locus.
Oh JJ; Boctor BN; Jimenez CA; Lopez R; Koegel AK; Taschereau EO; Phan DT; Jacobsen SE; Slamon DJ
Hum Genet; 2008 Feb; 123(1):55-64. PubMed ID: 18038152
[TBL] [Abstract][Full Text] [Related]
16. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].
Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916
[TBL] [Abstract][Full Text] [Related]
17. Single-Hit Inactivation Drove Tumor Suppressor Genes Out of the X Chromosome during Evolution.
Wang X; Hu W; Li X; Huang D; Li Q; Chan H; Zeng J; Xie C; Chen H; Liu X; Gin T; Wang MH; Cheng ASL; Kang W; To KF; Plewczynski D; Zhang Q; Chen X; Chan DCW; Ko H; Wong SH; Yu J; Chan MTV; Zhang L; Wu WKK
Cancer Res; 2022 Apr; 82(8):1482-1491. PubMed ID: 35247889
[TBL] [Abstract][Full Text] [Related]
18. Loss of Heterozygosity in BRCA1 and BRCA2 Genes in Patients with Ovarian Cancer and Probability of Its Use for Clinical Classification of Variations.
Kechin AA; Boyarskikh UA; Ermolenko NA; Tyulyandina AS; Lazareva DG; Avdalyan AM; Tyulyandin SA; Kushlinskii NE; Filipenko ML
Bull Exp Biol Med; 2018 May; 165(1):94-100. PubMed ID: 29797126
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.
van Wezel T; Lombaerts M; van Roon EH; Philippo K; Baelde HJ; Szuhai K; Cornelisse CJ; Cleton-Jansen AM
Breast Cancer Res; 2005; 7(6):R998-1004. PubMed ID: 16280054
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer.
Liu MC; Choong DY; Hooi CS; Williams LH; Campbell IG
Cancer Lett; 2007 Mar; 247(1):91-7. PubMed ID: 16644110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
